Comparison of the Pharmacokinetics of Raltegravir Given at 2 Doses of 400 mg by Swallowing Versus One Dose of 800 mg by Chewing in Healthy Volunteers
Dario Cattaneo(ASST Fatebenefratelli Sacco), Cristina Gervasoni(University of Padua), Emilio Clementi(Luigi Sacco Hospital), Amedeo Capetti(Luigi Sacco Hospital), Giuliano Rizzardini, Simona Landonio(ASST Fatebenefratelli Sacco), Sara Baldelli(Luigi Sacco Hospital), Paola Meraviglia(Luigi Sacco Hospital), Chiara Resnati(Luigi Sacco Hospital), Agostino Riva(ASST Fatebenefratelli Sacco), Maria Vittoria Cossu(Luigi Sacco Hospital), Serena Fucile(Luigi Sacco Hospital), Caterina Impagnatiello(Luigi Sacco Hospital), Massimo Galli(Luigi Sacco Hospital)
Cited by 2
Related Papers
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|589
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals
|Proceedings of the National Academy of Sciences|2004|496
Autophagy as a new therapeutic target in Duchenne muscular dystrophy
|Cell Death and Disease|2012|265